Pathogenica Bets on Targeted Sequencing to Drive Outbreak Monitoring in Hospital Settings | GenomeWeb

Pathogen sequencing company Pathogenica has developed a targeted sequencing-based kit for hospital-acquired infections that it said will help drive clinical adoption of sequencing for monitoring hospital outbreaks.

As part of the global launch of its HAI Biodetection Kit, Boston-based Pathogenica said last week that it has partnered with Life Technologies to co-market and distribute the kit in European, Middle Eastern, and Africa companies, expanding a similar deal it inked with Life Tech in May for Japan.

Get the full story with
GenomeWeb Premium

Only $95 for the
first 90 days*

A trial upgrade to GenomeWeb Premium gives you full site access, interest-based email alerts, access to archives, and more. Never miss another important industry story.

Try GenomeWeb Premium now.

Already a GenomeWeb Premium member? Login Now.
Or, See if your institution qualifies for premium access.

*Before your trial expires, we’ll put together a custom quote with your long-term premium options.

Not ready for premium?

Browse our free articles
You can still register for access to our free content.

In Science this week: CRISPR-based barcodes to trace cell lineages, and more.

The director of the National Institutes of Health Francis Collins sang the national anthem this week before a baseball game.

French researchers criticize unexpected government plan to cut research funding, ScienceInsider reports.

Regeneron Pharmaceuticals is to be the new sponsor of the prestigious high school Science Talent Search competition, according to the New York Times.